Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)

58.77
BATS BZX Real-Time Price
As of 11:45am ET
 -1.14 / -1.90%
Today’s Change
27.58
Today|||52-Week Range
67.66
+109.74%
Year-to-Date
Why You Should Retain UnitedHealth Group (UNH) Stock Now
10:12am / Zacks.com - Paid Partner Content
Here's Why Investors Should Retain Molina Healthcare (MOH) Now
Nov 28 / Zacks.com - Paid Partner Content
3 Best Momentum Stocks to Buy Using the Driehaus Strategy
6:08am / Zacks.com - Paid Partner Content
Here's Why You Should Invest in Centene (CNC) Stock Now
Nov 23 / Zacks.com - Paid Partner Content
Centene (CNC) Wins Contract From Arizona's Medicaid Agency
Dec 04 / Zacks.com - Paid Partner Content
3 Reasons Why Growth Investors Shouldn't Overlook Amphastar (AMPH)
Nov 22 / Zacks.com - Paid Partner Content
4 Top-Performing Liquid Stock Picks for Robust Returns
Nov 30 / Zacks.com - Paid Partner Content
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
Nov 22 / Zacks.com - Paid Partner Content
Amphastar (AMPH) Is Considered a Good Investment by Brokers: Is That True?
Nov 29 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close59.91
Today’s open59.66
Day’s range57.81 - 59.86
Volume4,519
Average volume (3 months)439,666
Market cap$2.8B
Data as of 11:45am ET, 12/05/2023

Growth & Valuation

Earnings growth (last year)+44.78%
Earnings growth (this year)+30.40%
Earnings growth (next 5 years)+22.62%
Revenue growth (last year)+13.98%
P/E ratio23.0
Price/Sales2.94
Price/Book5.27

Competitors

----
KRYSKrystal Biotech Inc-0.52-0.50%
XENEXenon Pharmaceutical...-0.23-0.61%
PBHPrestige Consumer He...+0.25+0.41%
Data as of 11:50am ET, 12/05/2023

Financials

Next reporting dateMarch 11, 2024
EPS forecast (this quarter)$0.70
Annual revenue (last year)$499.0M
Annual profit (last year)$91.4M
Net profit margin18.31%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Rancho Cucamonga, California

Forecasts